A systematic analysis of safety profile of Brexanolone in real-world use based on FAERS database
database[Title] 2025-04-26
Summary:
CONCLUSION: The introduction of Brexanolone has brought new hope to postpartum depression treatment, yet the study identifies a range of AEs, particularly associated with intravenous infusion and mental status changes, emphasizing caution in clinical application.